$TMO

$TMO is positioned higher as healthcare momentum accelerates, reinforcing a long-standing position rather than representing a fresh directional call today.

$TMO may see minor backing and filling after new highs, but its long-term base breakout following five years of range-bound activity remains constructive.

$TMO has broken above resistance with strong follow-through and improving relative strength, signaling health-care leadership despite a weak broader market.

$TMO has powered above resistance near 630 and continued higher, with strong follow-through and relative strength supporting the ongoing uptrend.

Thermo Fisher Scientific made a new 52-week high above $610 and delivered continued upside follow-through, supported by rising relative performance.